Analyst Articles – US

Plains All American Pipeline, L.P. (PAA) Price Target Cut to $26.00

Plains All American Pipeline, L.P. (NYSE:PAA) had its price target dropped by analysts at JPMorgan Chase & Co. from $27.00 to $26.00 in a research note issued to investors on Friday. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.’s price objective would indicate a potential upside of 16.85% from […]

AstraZeneca plc (AZN) Rating Reiterated by Goldman Sachs

AstraZeneca plc (NYSE:AZN)‘s stock had its “sell” rating reiterated by research analysts at Goldman Sachs in a report released on Friday. Several other brokerages also recently weighed in on AZN. Cantor Fitzgerald initiated coverage on AstraZeneca plc in a report on Friday, February 26th. They issued a “buy” rating for the company. Sanford C. Bernstein […]

Trina Solar Limited (TSL) Stock Rating Reaffirmed by Axiom Securities

Trina Solar Limited (NYSE:TSL)‘s stock had its “sell” rating restated by equities research analysts at Axiom Securities in a research report issued on Friday. They presently have a $4.00 target price on the stock, down from their previous target price of $6.00. Axiom Securities’ price objective would suggest a potential downside of 51.10% from the […]

Mizuho Boosts Oncomed Pharmaceuticals Inc (OMED) Price Target to $16.00

Oncomed Pharmaceuticals Inc (NASDAQ:OMED) had its target price raised by Mizuho from $15.00 to $16.00 in a report released on Thursday. They currently have a buy rating on the biopharmaceutical company’s stock. OMED has been the subject of a number of other reports. Cantor Fitzgerald reiterated a buy rating and set a $16.00 price objective […]

Mizuho Boosts Oncomed Pharmaceuticals Inc (OMED) Price Target to $16.00

Oncomed Pharmaceuticals Inc (NASDAQ:OMED) had its price target boosted by Mizuho from $15.00 to $16.00 in a research report released on Thursday. The firm currently has a buy rating on the biopharmaceutical company’s stock. Shares of Oncomed Pharmaceuticals (NASDAQ:OMED) opened at 14.62 on Thursday. Oncomed Pharmaceuticals has a 52-week low of $8.42 and a 52-week […]

Colfax Corp (CFX) Lifted to “Equal Weight” at Barclays

Barclays upgraded shares of Colfax Corp (NYSE:CFX) from an underweight rating to an equal weight rating in a research report report published on Wednesday morning. The firm currently has $26.00 target price on the stock, up from their previous target price of $24.00. The analysts noted that the move was a valuation call. CFX has […]

Chico's FAS, Inc. (CHS) PT Lowered to $11.00

Chico's FAS, Inc. (NYSE:CHS) had its price objective cut by investment analysts at Citigroup Inc. from $13.00 to $11.00 in a note issued to investors on Friday. The firm currently has a “neutral” rating on the stock. Citigroup Inc.’s price target would indicate a potential upside of 2.04% from the company’s current price. In other […]

Chico's FAS, Inc. (CHS) PT Lowered to $11.00

Chico's FAS, Inc. (NYSE:CHS) had its target price decreased by equities researchers at Citigroup Inc. from $13.00 to $11.00 in a research note issued to investors on Friday. The brokerage presently has a “neutral” rating on the stock. Citigroup Inc.’s price objective suggests a potential upside of 2.04% from the stock’s previous close. Shares of […]

Deutsche Bank Lowers Trina Solar Limited (TSL) to Hold

Deutsche Bank cut shares of Trina Solar Limited (NYSE:TSL) from a buy rating to a hold rating in a research note released on Thursday morning. Deutsche Bank currently has $9.00 price objective on the stock, down from their prior price objective of $11.00. “executing well in a robust demand environment in the US and China. […]

FBR & Co. Reaffirms Buy Rating for Dycom Industries, Inc. (DY)

FBR & Co. restated their buy rating on shares of Dycom Industries, Inc. (NYSE:DY) in a research report sent to investors on Thursday. Several other equities analysts also recently weighed in on DY. Zacks Investment Research downgraded Dycom Industries from a buy rating to a hold rating in a research report on Monday, February 22nd. […]

Jefferies Group Increases Ulta Salon, Cosmetics & Fragrance, Inc. (ULTA) Price Target to $215.00

Ulta Salon, Cosmetics & Fragrance, Inc. (NASDAQ:ULTA) had its price objective lifted by analysts at Jefferies Group from $180.00 to $215.00 in a report issued on Friday. The brokerage presently has a “hold” rating on the stock. Jefferies Group’s price target would indicate a potential downside of 7.78% from the company’s current price. Other large […]

Ulta Salon, Cosmetics & Fragrance, Inc. (ULTA) PT Raised to $250.00 at KeyBanc

Ulta Salon, Cosmetics & Fragrance, Inc. (NASDAQ:ULTA) had its price target upped by equities research analysts at KeyBanc from $220.00 to $250.00 in a note issued to investors on Friday. The brokerage currently has an “overweight” rating on the stock. KeyBanc’s price target indicates a potential upside of 7.23% from the stock’s current price. A […]

Ulta Salon, Cosmetics & Fragrance, Inc. (ULTA) PT Raised to $285.00 at Buckingham Research

Ulta Salon, Cosmetics & Fragrance, Inc. (NASDAQ:ULTA) had its price objective lifted by analysts at Buckingham Research from $225.00 to $285.00 in a report released on Friday. The firm presently has a “buy” rating on the stock. Buckingham Research’s price objective indicates a potential upside of 22.24% from the company’s current price. Other research analysts […]

Credit Suisse Reiterates Outperform Rating for BHP Billiton plc (BBL)

BHP Billiton plc (NYSE:BBL)‘s stock had its “outperform” rating reiterated by Credit Suisse in a research note issued to investors on Friday. Several other brokerages have also recently commented on BBL. Beaufort Securities reissued a “hold” rating on shares of BHP Billiton plc in a report on Saturday, April 23rd. Deutsche Bank reissued a “hold” […]

Neovasc Inc. (NVCN) Raised to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of Neovasc Inc. (NASDAQ:NVCN) from a sell rating to a hold rating in a research note released on Thursday. According to Zacks, “Neovasc Inc. is a specialty medical device company. It develops, manufactures and markets products for the cardiovascular marketplace. The Company’s products include the Tiara (TM) mitral valve prosthesis […]

Neovasc Inc. (NVCN) Raised to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of Neovasc Inc. (NASDAQ:NVCN) from a sell rating to a hold rating in a research note issued to investors on Thursday. According to Zacks, “Neovasc Inc. is a specialty medical device company. It develops, manufactures and markets products for the cardiovascular marketplace. The Company’s products include the Tiara (TM) mitral […]

Healthequity Inc (HQY) Downgraded by Zacks Investment Research to Hold

Zacks Investment Research cut shares of Healthequity Inc (NASDAQ:HQY) from a strong-buy rating to a hold rating in a research report report published on Monday morning. According to Zacks, “HealthEquity, Inc. is a technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions. The Company’s platform provides an ecosystem where consumers can […]

Charles Schwab Corp (SCHW) PT Raised to $35.00

Charles Schwab Corp (NYSE:SCHW) had its price objective raised by research analysts at Deutsche Bank from $33.00 to $35.00 in a research report issued on Friday. The brokerage currently has a “buy” rating on the stock. Deutsche Bank’s price target would indicate a potential upside of 14.27% from the company’s current price. SCHW has been […]

Flexion Therapeutics Inc (FLXN) Rating Reiterated by Needham & Company LLC

Flexion Therapeutics Inc (NASDAQ:FLXN)‘s stock had its “buy” rating reissued by research analysts at Needham & Company LLC in a note issued to investors on Friday. They presently have a $34.00 price objective on the specialty pharmaceutical company’s stock, up from their prior price objective of $28.00. Needham & Company LLC’s price objective indicates a […]

ePlus Inc. (PLUS) Stock Rating Lowered by Zacks Investment Research

ePlus Inc. (NASDAQ:PLUS) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Friday. According to Zacks, “ePlus Inc. serves as the parent holding company for ePlus Group, Inc., ePlus Technology of NC, Inc., ePlus Technology of PA, Inc., ePlus Technology, Inc., ePlus Government, Inc., […]

Cencosud SA (CNCO) Raised to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of Cencosud SA (NYSE:CNCO) from a sell rating to a hold rating in a report released on Thursday morning. According to Zacks, “Cencosud SA operates as a retail conglomerate in Latin America with operations in Argentina, Brazil, Chile and Peru. It operates supermarkets, home centers, department stores, shopping malls, family […]

WebMD Health Corp. (WBMD) Upgraded to “Buy” at Vetr Inc.

Vetr upgraded shares of WebMD Health Corp. (NASDAQ:WBMD) from a hold rating to a buy rating in a report issued on Monday. They currently have $68.50 price objective on the stock. Other hedge funds and institutional investors have added to or reduced their stakes in the company. Meeder Asset Management Inc. acquired a new position […]

L-3 Communications Holdings, Inc. (LLL) Raised to Buy at Drexel Hamilton

Drexel Hamilton upgraded shares of L-3 Communications Holdings, Inc. (NYSE:LLL) from a hold rating to a buy rating in a report issued on Thursday. Drexel Hamilton currently has $152.00 price target on the stock. In other L-3 Communications Holdings news, insider John S. Mega sold 7,567 shares of L-3 Communications Holdings stock in a transaction […]

Bank of America Lowers Hilton Worldwide Holdings Inc (HLT) to Neutral

Bank of America downgraded shares of Hilton Worldwide Holdings Inc (NYSE:HLT) from a buy rating to a neutral rating in a report issued on Thursday morning. Bank of America currently has $23.00 target price on the stock. A number of other equities analysts also recently issued reports on the company. Citigroup Inc. increased their price […]

L-3 Communications Holdings, Inc. (LLL) Lifted to “Outperform” at RBC Capital

RBC Capital upgraded shares of L-3 Communications Holdings, Inc. (NYSE:LLL) from a sector perform rating to an outperform rating in a research note issued to investors on Thursday morning. They currently have $150.00 price objective on the stock. Shares of L-3 Communications Holdings (NYSE:LLL) opened at 137.89 on Thursday. L-3 Communications Holdings has a 52-week […]